Literature DB >> 15001156

Immunotherapy of melanoma: the good news, the bad ones and what to do next.

Francesco M Marincola, Soldano Ferrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15001156     DOI： 10.1016/j.semcancer.2003.09.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


× No keyword cloud information.
  5 in total

1.  Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Authors:  Ying-Tao Zhang; Yi-Ping Geng; Le Zhou; Bao-Chang Lai; Lv-Sheng Si; Yi-Li Wang
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

Review 2.  Understanding the response to immunotherapy in humans.

Authors:  Ena Wang; Monica C Panelli; Francesco M Marincola
Journal:  Springer Semin Immunopathol       Date:  2005-01-22

Review 3.  Gene-expression profiling in vaccine therapy and immunotherapy for cancer.

Authors:  Davide Bedognetti; Ena Wang; Mario Roberto Sertoli; Francesco M Marincola
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

Review 4.  Overview of melanoma vaccines and promising approaches.

Authors:  Monica C Panelli; Ena Wang; Vladia Monsurrò; Ping Jin; Katia Zavaglia; Kina Smith; Yvonne Ngalame; Francesco M Marincola
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

5.  A balanced review of the status T cell-based therapy against cancer.

Authors:  Francesco M Marincola
Journal:  J Transl Med       Date:  2005-04-14       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.